ArticleBMJ open2020

Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol.

Rui Qian Yeu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.